Description

Methyl Drostanolone 10 mg

Marque : Magnus Pharmaceuticals
Contenu : 100 tablets | 10 mg per tablet
Prix : €44
Fabriqué en : L'Europe

🧪 Product Overview

Methyl Drostanolone 10 mg delivers the potent designer steroid known as Superdrol (methasterone), a 17-α-alkylated DHT-derived compound developed for strength and hypertrophy modeling in lab environments. With 3–5× the AR affinity of testosterone, it produces rapid muscle-mass and strength increases—balanced by a high risk of hepatotoxicity.

The compound’s ~8–10 h half-life and near-total oral bioavailability allow for precise oral-dosing studies. It remains banned under WADA S1, and detectable via long-term urinary markers.

✅ Key Research Highlights

Extreme anabolic drive: Demonstrates superior androgen-receptor binding vs. testosterone, supporting explosive hypertrophy research
Fast-response protocols: 4–6 week dosing yields significant body-mass and nitrogen-retention gains in resistance-trained subjects
Non-aromatising structure: Prevents estrogenic water gain and gynecomastia, useful in lean-mass studies
Oral bioavailability ~100%: Allows high-efficiency delivery without injection models
High detection sensitivity: Novel 17-epi metabolites enable LC-MS/MS detection >2 weeks post-dose
WADA status: Fully banned as an S1 anabolic agent—any exposure will yield a positive doping test

🔬 Suggested Laboratory Applications

Strength-gain and lean-hypertrophy modeling
Nitrogen retention and glycogen utilization studies
Hepatotoxicity mechanism mapping
Anti-doping detection validation
Androgen–receptor activation assays

📊 Technical Specifications

Champ d'application	Données
Nom chimique	Methasterone (Methyldrostanolone)
Formule chimique	C<sub>21</sub>H<sub>34</sub>O<sub>2</sub>
Synonymes	Superdrol; SDR; 2α,17α-dimethyl-5α-androstan-17β-ol-3-one
Poids moléculaire	318.5 g/mol
Numéro CAS	3381-88-2
Half-life (oral)	≈ 8–10 h; peak concentration at 1–2 h
Avantages documentés	↑ Lean muscle mass, ↑ strength, ↓ estrogenic water retention
Principaux risques	Hepatotoxicity, jaundice, renal stress, lipid disruption, mood lability
Composé actif total	1,000 mg per carton (10 mg × 100 tablets)
Durée de conservation	36 months (manufacturer specification)
Fenêtre de détection	> 14 days via LC-MS/MS urinary metabolites

⚙️ PubChem-Supported Research Insights

Provides aggressive lean-mass and strength gain in short-cycle models
Non-aromatising design limits estrogen-related side effects
Documented in multiple hepatotoxicity and dyslipidaemia case reports
Maintains high androgenic activity with no estrogen conversion

⚠️ Documented Research Side Effects

Cholestatic jaundice and hepatocellular stress after 2–7 weeks
Renal stress and hypertension reported in dose-escalation studies
HDL↓ / LDL↑ lipid shift, mood instability, and aggression risk
Virtually guaranteed anti-doping violation from metabolite trace detection

🧯 Handling & Compliance

Réservé à la recherche — Not for human or veterinary use
Store at ≤ 25°C in dry, light-protected conditions
Purchase confirms qualified researcher status
WADA-listed substance — doping test positive on any exposure